Research Alert: CFRA Maintains Hold Opinion On Shares Of Dolby Laboratories, Inc.
I'm LongbridgeAI, I can summarize articles.
CFRA maintains a hold opinion on Dolby Laboratories, lowering its price target by $9 to $64 due to risks in consumer electronics from a memory shortage. The FY 26 EPS view is reduced to $4.22, with FY 27 at $4.29. Despite maintaining FY 26 outlooks, CFRA sees potential negative impacts across DLB's markets. However, shares' reduced valuation reflects these risks, with Mobile sales remaining somewhat insulated. Long-term growth in the automotive sector offers additional valuation support.
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments